This trust offers the following services:

• Acute services:
• On-site bowel stenting facilities

• Advanced disease services:
• Dedicated Specialist Advanced MDT

• Diagnostic and pre-operative services:
• Routine Genetic Testing for Lynch Syndrome

All Patients:	Trust	Network	National
Number of patients in Audit	170	1558	35779
Case ascertainment (%)	Good	Fair	Good
Data completeness of:
– Pre-treatment TNM (%)	91	81	86
– Performance status (%)	90	78	89

Patients having major resection:	Trust	Network	National
Number of patients in Audit	113	848	19631
ASA grade 1 (%)	13	22	9
ASA grade 2 (%)	73	52	53
ASA grade 3 (%)	8	21	31
ASA grade 4+ (%)	N/A	1	2
ASA grade not recorded (%)	5	4	4
Data completeness of:
7 Audit items for risk-adjustment (%)	93	93	87

All Patients:	Trust	Network	National
Number of patients in Audit	170	1558	35779
Seen by Clinical Nurse Specialist (%)	92	85	88

Patients having major resection:	Trust	Network	National
Number of patients in Audit	113	848	19614
Distant metastases (%)	10	6	5
Urgent or emergency surgery (%)	8	10	15
At least 12 lymph nodes excised (%)	93	93	84
Laparoscopic surgery attempted (%)	68	63	72
Risk-adjusted length of stay > 5 days (%)	65	74	55

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	67	N/A	10747
Adjuvant chemotherapy (%)	55	N/A	62

Patients receiving chemotherapy after major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	N/A	N/A	6608
Severe acute toxicity after adjuvant chemotherapy (%)	N/A	N/A	22

Patients having major resection:	Trust	Network	National
Number of patients in Audit	21	N/A	4251
Neoadjuvant therapy (%)	40	N/A	33
Circumferential resection margin: Recorded (%)	90	98	89
Circumferential resection margin: Negative (%)	81	94	83
Rectal volume	23	N/A	4377

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	68	985	19644
APER/Hartmanns (%)	18	31	37